Thomas L. Mindt, Ph.D. - Publications

Affiliations: 
2003 Brown University, Providence, RI 
Area:
Natural product total synthesis

38/58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chiotellis A, Sladojevich F, Mu L, Müller Herde A, Valverde IE, Tolmachev V, Schibli R, Ametamey SM, Mindt TL. Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions. Chemical Communications (Cambridge, England). PMID 27043419 DOI: 10.1039/c6cc01982j  0.8
2015 Mascarin A, Valverde IE, Mindt TL. Structure-Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates. Chemmedchem. PMID 26593062 DOI: 10.1002/cmdc.201500468  0.8
2015 Mascarin A, Valverde IE, Vomstein S, Mindt TL. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting. Bioconjugate Chemistry. 26: 2143-52. PMID 26347939 DOI: 10.1021/acs.bioconjchem.5b00444  0.8
2015 Valverde IE, Vomstein S, Fischer CA, Mascarin A, Mindt TL. Probing the Backbone Function of Tumor Targeting Peptides by an Amide-to-Triazole Substitution Strategy. Journal of Medicinal Chemistry. 58: 7475-84. PMID 26309061 DOI: 10.1021/acs.jmedchem.5b00994  0.8
2015 Bauman A, Valverde IE, Fischer CA, Vomstein S, Mindt TL. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1569-74. PMID 26251418 DOI: 10.2967/jnumed.115.159186  0.8
2015 Parker KA, Mindt TL. Regioselective 1,2-addition of organometallic reagents to unprotected juglones Tetrahedron Letters. 56: 3500-3502. DOI: 10.1016/j.tetlet.2014.12.108  0.8
2014 Aerts J, Ballinger JR, Behe M, Decristoforo C, Elsinga PH, Faivre-Chauvet A, Mindt TL, Kolenc Peitl P, Todde SC, Koziorowski J. Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 615-20. PMID 25196257 DOI: 10.1002/jlcr.3227  0.8
2014 Patra M, Bauman A, Mari C, Fischer CA, Blacque O, Häussinger D, Gasser G, Mindt TL. An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes Chemical Communications. 50: 11523-11525. PMID 25132321 DOI: 10.1039/c4cc05558f  0.8
2014 Todde S, Windhorst AD, Behe M, Bormans G, Decristoforo C, Faivre-Chauvet A, Ferrari V, Gee AD, Gulyas B, Halldin C, Peitl PK, Koziorowski J, Mindt TL, Sollini M, Vercouillie J, et al. EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD). European Journal of Nuclear Medicine and Molecular Imaging. 41: 2175-85. PMID 25081821 DOI: 10.1007/s00259-014-2866-8  0.8
2014 Fischer CA, Vomstein S, Mindt TL. A bombesin-shepherdin radioconjugate designed for combined extra- and intracellular targeting. Pharmaceuticals (Basel, Switzerland). 7: 662-75. PMID 24871806 DOI: 10.3390/ph7060662  0.8
2014 Cordier D, Gerber A, Kluba C, Bauman A, Hutter G, Mindt TL, Mariani L. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy. Cancer Biotherapy & Radiopharmaceuticals. 29: 221-6. PMID 24552486 DOI: 10.1089/cbr.2013.1588  0.8
2014 Valverde IE, Huxol E, Mindt TL. Radiolabeled antagonistic bombesin peptidomimetics for tumor targeting. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 275-8. PMID 24327435 DOI: 10.1002/jlcr.3162  0.8
2013 Valverde IE, Bauman A, Kluba CA, Vomstein S, Walter MA, Mindt TL. 1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting. Angewandte Chemie (International Ed. in English). 52: 8957-60. PMID 23832715 DOI: 10.1002/anie.201303108  0.8
2013 Kluba CA, Mindt TL. Click-to-Chelate: development of technetium and rhenium-tricarbonyl labeled radiopharmaceuticals. Molecules (Basel, Switzerland). 18: 3206-26. PMID 23481882 DOI: 10.3390/molecules18033206  0.8
2013 Mascarin A, Valverde IE, Mindt TL. Effect of a spacer moiety on radiometal labelled Neurotensin derivatives Radiochimica Acta. 101: 733-737. DOI: 10.1524/ract.2013.2090  0.8
2012 Kluba CA, Bauman A, Valverde IE, Vomstein S, Mindt TL. Dual-targeting conjugates designed to improve the efficacy of radiolabeled peptides. Organic & Biomolecular Chemistry. 10: 7594-602. PMID 22898743 DOI: 10.1039/c2ob26127h  0.8
2012 Ng QKT, Segura T, Ben-Shlomo A, Krause T, Mindt TL, Walter MA. The Influence of different metal-chelators on the biological profile of nanoparticles for gallium-68 based molecular imaging Journal of Nano Research. 20: 21-31. DOI: 10.4028/www.scientific.net/JNanoR.20.21  0.8
2011 Parker KA, Mindt TL. Convergent Synthesis of 2H-Chromenes - a Formal [3+3] Cycloaddition by a One-pot, Three-Step Cascade. Tetrahedron. 67: 9779-9786. PMID 22259219 DOI: 10.1016/j.tet.2011.09.068  0.8
2011 Arrowsmith RL, Waghorn PA, Jones MW, Bauman A, Brayshaw SK, Hu Z, Kociok-Köhn G, Mindt TL, Tyrrell RM, Botchway SW, Dilworth JR, Pascu SI. Fluorescent gallium and indium bis(thiosemicarbazonates) and their radiolabelled analogues: synthesis, structures and cellular confocal fluorescence imaging investigations. Dalton Transactions (Cambridge, England : 2003). 40: 6238-52. PMID 21594287 DOI: 10.1039/c1dt10126a  0.8
2011 Giovacchini G, Nicolas G, Freidank H, Mindt TL, Forrer F. Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1675-82. PMID 21553088 DOI: 10.1007/s00259-011-1826-9  0.8
2011 Piscaer TM, Müller C, Mindt TL, Lubberts E, Verhaar JA, Krenning EP, Schibli R, De Jong M, Weinans H. Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography. Arthritis and Rheumatism. 63: 1898-907. PMID 21437875 DOI: 10.1002/art.30363  0.8
2010 Mindt TL, Struthers H, Spingler B, Brans L, Tourwé D, García-Garayoa E, Schibli R. Molecular assembly of multifunctional 99mTc radiopharmaceuticals using "clickable" amino acid derivatives Chemmedchem. 5: 2026-2038. PMID 20922747 DOI: 10.1002/cmdc.201000342  0.8
2010 Struthers H, Mindt TL, Schibli R. Metal chelating systems synthesized using the copper(I) catalyzed azide-alkyne cycloaddition. Dalton Transactions (Cambridge, England : 2003). 39: 675-96. PMID 20066208 DOI: 10.1039/b912608b  0.8
2009 Mindt TL, Müller C, Stuker F, Salazar JF, Hohn A, Mueggler T, Rudin M, Schibli R. A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor. Bioconjugate Chemistry. 20: 1940-9. PMID 19803478 DOI: 10.1021/bc900276b  0.8
2009 Mindt TL, Schweinsberg C, Brans L, Hagenbach A, Abram U, Tourwé D, Garcia-Garayoa E, Schibli R. A click approach to structurally diverse conjugates containing a central di-1,2,3-triazole metal chelate. Chemmedchem. 4: 529-39. PMID 19235821 DOI: 10.1002/cmdc.200800418  0.8
2009 Müller C, Mindt TL, de Jong M, Schibli R. Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 36: 938-46. PMID 19183997 DOI: 10.1007/s00259-008-1058-9  0.8
2008 Ross TL, Honer M, Lam PYH, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative Bioconjugate Chemistry. 19: 2462-2470. PMID 19053298 DOI: 10.1021/bc800356r  0.8
2008 Mindt TL, Müller C, Melis M, de Jong M, Schibli R. "Click-to-chelate": in vitro and in vivo comparison of a 99mTc(CO)3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue. Bioconjugate Chemistry. 19: 1689-95. PMID 18646835 DOI: 10.1021/bc800183r  0.8
2008 Struthers H, Spingler B, Mindt TL, Schibli R. "Click-to-chelate": design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest. Chemistry (Weinheim An Der Bergstrasse, Germany). 14: 6173-6183. PMID 18494020 DOI: 10.1002/chem.200702024  0.8
2008 Mindt TL, Jungi V, Wyss S, Friedli A, Pla G, Novak-Hofer I, Grünberg J, Schibli R. Modification of different IgG1 antibodies via glutamine and lysine using bacterial and human tissue transglutaminase. Bioconjugate Chemistry. 19: 271-8. PMID 17988081 DOI: 10.1021/bc700306n  0.8
2007 Mindt TL, Schibli R. Cu(I)-catalyzed intramolecular cyclization of alkynoic acids in aqueous media: a "click side reaction". The Journal of Organic Chemistry. 72: 10247-50. PMID 18044929 DOI: 10.1021/jo702030e  0.8
2007 Mindt T, Struthers H, Garcia-Garayoa E, Desbouis D, Schibli R. Strategies for the development of novel tumor targeting technetium and rhenium radiopharmaceuticals Chimia. 61: 725-731. DOI: 10.2533/chimia.2007.725  0.8
2006 Mindt TL, Struthers H, Brans L, Anguelov T, Schweinsberg C, Maes V, Tourwé D, Schibli R. "Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step. Journal of the American Chemical Society. 128: 15096-7. PMID 17117854 DOI: 10.1021/ja066779f  0.8
2006 Parker KA, Mindt TL, Koh YH. TESOTf-induced rearrangement of quinols. Efficient construction of the fully functionalized carbon skeleton of the griseusins by a divergent-reconvergent approach. Organic Letters. 8: 1759-62. PMID 16623544 DOI: 10.1021/ol060206q  0.8
2002 Parker KA, Mindt TL. Heterocycle annulation of enolizable vinyl quinone imides. Dihydroquinolines and quinolines from thermal 6pi-electrocyclizations and indoles from photochemical cyclizations. Organic Letters. 4: 4265-8. PMID 12443074 DOI: 10.1021/ol026849x  0.8
2001 Parker KA, Mindt TL. Electrocyclic ring closure of the enols of vinyl quinones. A 2H-chromene synthesis. Organic Letters. 3: 3875-8. PMID 11720558 DOI: 10.1021/ol0167199  0.8
1999 Mindt T, Michel U, Dick F. Synthesis and evaluation of enantiomeric purity of protected α-amino and peptide aldehydes Helvetica Chimica Acta. 82: 1960-1968. DOI: 10.1002/(SICI)1522-2675(19991110)82:11<1960::AID-HLCA1960>3.0.CO;2-2  0.8
1995 Acemoglu M, Bantle S, Mindt T, Nimmerfall F. Novel bioerodible poly(hydroxyalkylene carbonates)s: a versatile class of polymers for medical and pharmaceutical applications Macromolecules. 28: 3030-3037.  0.8
Low-probability matches
2018 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29331022 DOI: 10.1002/jlcr.3604  0.08
2017 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight. Nuclear Medicine and Biology. PMID 29074076 DOI: 10.1016/j.nucmedbio.2017.09.004  0.08
2019 Kaeppeli SAM, Schibli R, Mindt TL, Behe M. Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4. Ejnmmi Radiopharmacy and Chemistry. 4: 9. PMID 31659487 DOI: 10.1186/s41181-019-0060-9  0.01
2019 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines. Ejnmmi Radiopharmacy and Chemistry. 4: 7. PMID 31659484 DOI: 10.1186/s41181-018-0047-y  0.01
2019 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative. Nuclear Medicine and Biology. 71: 19-22. PMID 31128474 DOI: 10.1016/j.nucmedbio.2019.05.001  0.01
2019 Brandt M, Cardinale J, Rausch I, Mindt TL. Manganese in PET imaging - opportunities and challenges. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 31115089 DOI: 10.1002/jlcr.3754  0.01
2019 Brandt M, Cardinale J, Giammei C, Guarrochena X, Happl B, Jouini N, Mindt TL. Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders. Nuclear Medicine and Biology. 70: 46-52. PMID 30831342 DOI: 10.1016/j.nucmedbio.2019.01.006  0.01
2018 Brandt M, Cardinale J, Aulsebrook M, Gasser G, Mindt T. AN OVERVIEW ON PET RADIOCHEMISTRY: PART 2 - RADIOMETALS. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29748237 DOI: 10.2967/jnumed.117.190801  0.01
2018 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Letter to the Editor: International Consensus Radiochemistry Nomenclature Guidelines. Current Radiopharmaceuticals. 11: 73-75. PMID 29624156 DOI: 10.2174/187447101101180404111248  0.01
2018 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. International Consensus Radiochemistry Nomenclature Guidelines. Nuklearmedizin. Nuclear Medicine. 57: 40-41. PMID 29536500 DOI: 10.1055/s-0038-1636563  0.01
2018 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines. American Journal of Nuclear Medicine and Molecular Imaging. 8: 70-72. PMID 29531863  0.01
2018 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines. Nuclear Medicine Communications. 39: 193-195. PMID 29438216 DOI: 10.1097/MNM.0000000000000799  0.01
2018 Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines. Annals of Nuclear Medicine. PMID 29423765 DOI: 10.1007/s12149-018-1238-z  0.01
2017 Briand M, Aulsebrook ML, Mindt TL, Gasser G. A solid phase-assisted approach for the facile synthesis of a highly water-soluble zirconium-89 chelator for radiopharmaceutical development. Dalton Transactions (Cambridge, England : 2003). PMID 29130082 DOI: 10.1039/c7dt03639f  0.01
2017 Maina T, Kaloudi A, Valverde IE, Mindt TL, Nock BA. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. Nuclear Medicine and Biology. 52: 57-62. PMID 28636973 DOI: 10.1016/j.nucmedbio.2017.06.001  0.01
2017 Grob NM, Behe M, von Guggenberg E, Schibli R, Mindt TL. Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates. Journal of Peptide Science : An Official Publication of the European Peptide Society. PMID 28054429 DOI: 10.1002/psc.2948  0.01
2016 Römhild K, Fischer CA, Mindt TL. Glycated (99m) Tc-Tricarbonyl-Labeled Peptide Conjugates for Tumor Targeting by "Click-to-Chelate". Chemmedchem. PMID 27902882 DOI: 10.1002/cmdc.201600485  0.01
2016 Vugts DJ, Klaver C, Sewing C, Poot AJ, Adamzek K, Huegli S, Mari C, Visser GW, Valverde IE, Gasser G, Mindt TL, van Dongen GA. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)Zr-immuno-PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27573793 DOI: 10.1007/s00259-016-3499-x  0.01
2016 Valverde IE, Vomstein S, Mindt TL. Towards the Optimization of Bombesin-Based Radiotracers for Tumor Targeting. Journal of Medicinal Chemistry. PMID 27054526 DOI: 10.1021/acs.jmedchem.6b00025  0.01
2013 Valverde IE, Mindt TL. 1,2,3-Triazoles as amide-bond surrogates in peptidomimetics. Chimia. 67: 262-6. PMID 23967702  0.01
Hide low-probability matches.